Analysts are split on whether the positive trial results will help Merck stem future Keytruda losses as the mega-blockbuster ...

Among 64 patients who received immune checkpoint inhibitors, 78% had downstaging of their liver tumor to within Milan ...

Discover six bispecific antibody companies developing a two-in-one approach to delivering targeted therapeutics to patients.